Literature DB >> 18528704

Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque.

Yuri V Bobryshev1, Murray C Killingsworth, Dihn Tran, Reginald Lord.   

Abstract

Chlamydia pneumoniae (Chlamydophila pneumoniae) infect macrophages and accelerates foam cell formation in in vitro experiments, but whether this might occur in human atherosclerosis is unknown. In the present study, we examined 17 carotid artery segments, obtained by endarterectomy, in which the presence of C. pneumoniae was confirmed by both polymerase chain reaction and immunohistochemistry. Electron microscopy demonstrated the presence of structures with the appearance of elementary, reticulate and aberrant bodies of C. pneumoniae in the cytoplasm of macrophage foam cells. The volume of the cytoplasm that was free from vacuoles and lipid droplets in C. pneumoniae-infected foam cells was dramatically reduced, and a phenomenon of the amalgamation of C. pneumoniae inclusions with lipid droplets was detected. Double immunohistochemistry showed that C. pneumoniae-infected foam cells contained a large number of oxidized low-density lipoproteins. The observations provide support to the hypothesis that C. pneumoniae could affect foam cell formation in human atherosclerosis.

Entities:  

Mesh:

Year:  2008        PMID: 18528704     DOI: 10.1007/s00428-008-0629-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  63 in total

1.  Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells.

Authors:  K Wolf; E Fischer; T Hackstadt
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 2.  Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.

Authors:  Murat V Kalayoglu; Peter Libby; Gerald I Byrne
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

3.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

4.  Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse.

Authors:  T C Moazed; C C Kuo; J T Grayston; L A Campbell
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 6.  Chlamydia pneumoniae and cardiovascular disease.

Authors:  L A Campbell; C C Kuo; J T Grayston
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

7.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.

Authors:  C C Kuo; A M Gown; E P Benditt; J T Grayston
Journal:  Arterioscler Thromb       Date:  1993-10

8.  Chlamydia pneumoniae in atherosclerotic lesions of patients undergoing vascular surgery.

Authors:  Florian Loehe; Iris Bittmann; Christine Weilbach; Lutz Lauterjung; Friedrich-Wilhelm Schildberg; Markus M Heiss
Journal:  Ann Vasc Surg       Date:  2002-07-08       Impact factor: 1.466

9.  Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions.

Authors:  Y V Bobryshev; R S Lord
Journal:  Cardiovasc Res       Date:  1998-03       Impact factor: 10.787

Review 10.  Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?

Authors:  Lee Ann Campbell; Cho-cho Kuo
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

View more
  6 in total

1.  Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts.

Authors:  Laura Mannonen; Eveliina Markkula; Mirja Puolakkainen
Journal:  Med Microbiol Immunol       Date:  2011-01-30       Impact factor: 3.402

2.  Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion.

Authors:  Juha T Korhonen; Mirja Puolakkainen; Reetta Häivälä; Tuula Penttilä; Anu Haveri; Eveliina Markkula; Riitta Lahesmaa
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

3.  Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation.

Authors:  Shuang Chen; Rosalinda Sorrentino; Kenichi Shimada; Yonca Bulut; Terence M Doherty; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 4.  Laboratory diagnosis of persistent human chlamydial infection.

Authors:  Mirja Puolakkainen
Journal:  Front Cell Infect Microbiol       Date:  2013-12-17       Impact factor: 5.293

Review 5.  Lipid Droplets: A Significant but Understudied Contributor of Host⁻Bacterial Interactions.

Authors:  Cassandra L Libbing; Adam R McDevitt; Rea-Mae P Azcueta; Ahila Ahila; Minal Mulye
Journal:  Cells       Date:  2019-04-15       Impact factor: 6.600

Review 6.  Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery Disease.

Authors:  James S Lawson
Journal:  Front Cardiovasc Med       Date:  2016-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.